Leukemia Home > Marquibo

Were you looking for information about Marqibo? Marquibo is a common misspelling of Marqibo.
If you have a form of cancer called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL), your healthcare provider may prescribe a chemotherapy drug called Marqibo® (liposomal vincristine sulfate). The medication is approved for use in adults, and is prescribed when at least two other forms of leukemia treatment have been tried and the cancer has returned or become worse.
Marqibo is injected into a vein (intravenously, or by IV) once every seven days by your healthcare provider. Side effects are common and may include constipation, nausea, and fatigue.
(Click Marqibo for more information on possible side effects, as well as safety precautions to review and factors affecting your dose. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.